A Novel Schmallenberg Virus Subunit Vaccine Candidate Protects IFNAR Mice Against Virulent SBV Challenge
Authors
Affiliations
Schmallenberg virus (SBV), an arthropod-transmitted pathogenic bunyavirus, continues to be a threat to the European livestock industry, causing morbidity and mortality among young ruminant livestock. Here, we describe a novel SBV subunit vaccine, based on bacterially expressed SBV nucleoprotein (SBV-N) administered with a veterinary-grade Saponin adjuvant. When assayed in an IFNAR mouse model, SBV-N with Saponin induced strong non-neutralizing broadly virus-reactive antibodies, decreased clinical signs, as well as significantly reduced viremia. Vaccination assays also suggest that this level of immune protection is cell mediated, as evidenced by the lack of neutralizing antibodies, as well as interferon-γ secretion observed in vitro. Therefore, based on these results, bacterially expressed SBV-N, co-administered with veterinary-grade Saponin adjuvant may serve as a promising economical alternative to current SBV vaccines, and warrant further evaluation in large ruminant animal models. Moreover, we propose that this strategy may be applicable to other bunyaviruses.
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21.
Leventhal S, Bisom T, Clift D, Rao D, Meade-White K, Shaia C Nat Commun. 2024; 15(1):9236.
PMID: 39455551 PMC: 11511847. DOI: 10.1038/s41467-024-53362-7.
Karaaslan E, Sorvillo T, Scholte F, ONeal T, Welch S, Davies K NPJ Vaccines. 2024; 9(1):148.
PMID: 39143104 PMC: 11324950. DOI: 10.1038/s41541-024-00931-y.
The Adaptive Immune Response against .
Alatrash R, Herrera B Viruses. 2024; 16(3).
PMID: 38543848 PMC: 10974645. DOI: 10.3390/v16030483.
Hartman A, Myler P J Infect Dis. 2023; 228(Suppl 6):S376-S389.
PMID: 37849397 PMC: 10582323. DOI: 10.1093/infdis/jiac338.
Wernike K, Aebischer A, Audonnet J, Beer M One Health Outlook. 2022; 4(1):13.
PMID: 35978443 PMC: 9383659. DOI: 10.1186/s42522-022-00069-8.